Leal Therapeutics, Inc
Clinical trials sponsored by Leal Therapeutics, Inc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new pill calm a schizophrenia Flare-Up? a trial seeks answers Results expected Mar 2027 (estimated)
-
New ALS drug targets genetic cause in early human trial
Disease control Recruiting nowThis study tests an investigational drug called LTX-002 in people with amyotrophic lateral sclerosis (ALS). The drug is designed to target a specific genetic message linked to the disease. The main goal is to check the drug's safety and tolerability, and to see how it moves throu…
Phase 1/2 • Sponsor: Leal Therapeutics, Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a new pill calm a schizophrenia Flare-Up? a trial seeks answers
Symptom relief Recruiting nowThis trial tests an experimental drug called LTX-001 in adults with schizophrenia who are experiencing a sudden worsening of symptoms. Participants stay in a research unit for about five weeks and receive either LTX-001 or a placebo. The main goal is to see if the drug is safe an…
Phase 1 • Sponsor: Leal Therapeutics, Inc • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC